Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.39 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.39 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.39 |
| ▸ | SELP | P16109 | 8/20 | 0.36 |
| ▸ | SELE | P16581 | 2/20 | 0.35 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.35 |
| ▸ | TACR2 | P21452 | 1/20 | 0.34 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.34 |
| ▸ | TACR1 | P25103 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14490088 | 0.90 | SLC6A2 (0.38) | NT5ELGALS8TACR2SSTR5TACR1 | |
| SCHEMBL13855505 | 0.86 | SSTR5 (0.37) | NT5ELGALS8TACR2SSTR5TACR1 | |
| SCHEMBL13298919 | 0.86 | NT5E (0.46) | NT5ESSTR5PTPN1 | |
| SCHEMBL13380992 | 0.82 | SSTR5 (0.39) | SSTR5TACR1SLC6A2 | |
| SCHEMBL13707193 | 0.82 | LGALS9 (0.43) | NT5ELGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL10148622 | 0.81 | LGALS9 (0.46) | NT5ELGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL11981213 | 0.81 | LGALS9 (0.46) | NT5ELGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL13855490 | 0.81 | LGALS3 (0.58) | NT5ELGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL10148626 | 0.81 | LGALS3 (0.58) | NT5ELGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL13707194 | 0.81 | LGALS9 (0.46) | NT5ELGALS9LGALS1LGALS3LGALS7; LGALS7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137793-A1 | DISACCHARIDE COMPOUNDS | ACADEMIA SINICA (TW) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137793-A1 | DISACCHARIDE COMPOUNDS | HPSE, DDOST, FUT5 | NT5E 835/4885LGALS9 170/4885LGALS1 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.